The clinical efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with Crohn's disease: A multicenter retrospective pilot study

被引：0

作者：

Ueno, Nobuhiro ^{[1
,2
,10
]}

Saito, Seisuke ^{[3
]}

Sato, Masahiro ^{[4
]}

Sugiyama, Yuya ^{[4
]}

Kobayashi, Yu ^{[4
]}

Murakami, Yuki ^{[4
]}

Sugimura, Kohjiro ^{[5
]}

Sasaki, Takahiro ^{[4
]}

Sakatani, Aki ^{[2
]}

Takahashi, Keitaro ^{[4
]}

Tanaka, Kazuyuki ^{[6
]}

Serikawa, Shinya ^{[7
]}

Ando, Katsuyoshi ^{[4
]}

Kashima, Shin ^{[4
]}

Muto, Momotaro ^{[8
]}

Inaba, Yuhei ^{[9
]}

Moriichi, Kentaro ^{[4
]}

Tanabe, Hiroki ^{[4
]}

Okumura, Toshikatsu ^{[4
]}

Fujiya, Mikihiro ^{[2
,4
]}

机构：

[1] Asahikawa Med Univ Hosp, Div Gen Med, Asahikawa, Hokkaido, Japan

[2] Asahikawa Med Univ, Dept Gastroenterol Sci, Asahikawa, Hokkaido, Japan

[3] Furano Hosp, Furano, Hokkaido, Japan

[4] Asahikawa Med Univ, Dept Internal Med, Div Gastroenterol, Asahikawa, Hokkaido, Japan

[5] Nakashibetsu Town Hosp, Nakashibetsu, Hokkaido, Japan

[6] Asahikawa Kosei Gen Hosp, Asahikawa, Hokkaido, Japan

[7] Nayoro City Gen Hosp, Nayoro, Hokkaido, Japan

[8] Engaru Kosei Gen Hosp, Engaru, Hokkaido, Japan

[9] Asahikawa City Hosp, Asahikawa, Hokkaido, Japan

[10] Asahikawa Med Univ Hosp, Div Gen Med, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan

来源：

THERAPEUTIC APHERESIS AND DIALYSIS | 2024年 / 28卷 / 03期

关键词：

biologics; clinical response; Crohn's disease; granulocyte and monocyte apheresis; loss of response;

D O I：

10.1111/1744-9987.14103

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction: A remission induction therapy of granulocyte and monocyte adsorptive apheresis (GMA) was given to patients with Crohn's disease (CD). However, establishing an appropriate treatment strategy for GMA in patients with CD remains unclear.Methods: This study evaluated the clinical efficacy and subsequent clinical progression after GMA in patients with CD who underwent GMA in seven independent institutions in Japan from 2010 to 2023.Results: Sixteen patients were enrolled. The overall remission and response rates were 25.0% and 68.8%, respectively. All patients responding to GMA received biologics that were continuously used and 36.4% of patients remained on the same biologics 52 weeks after GMA. Notably, all patients who continued the same biologics had previously experienced a loss of response to biologics.Conclusion: GMA may exhibit effectiveness even in cases with refractory CD. Moreover, it represents a potential novel therapeutic option for refractory CD with loss of response to biologics.

引用

页码：442 / 452

页数：11

共 50 条

[1] Adsorptive granulocyte and monocyte apheresis for refractory Crohn’s disease: an open multicenter prospective study
Yoshihiro Fukuda
Toshiyuki Matsui
Yasuo Suzuki
Kazunari Kanke
Takayuki Matsumoto
Masakazu Takazoe
Takayuki Matsumoto
Satoshi Motoya
Terasu Honma
Koji Sawada
Tsuneyoshi Yao
Takashi Shimoyama
Toshifumi Hibi
Journal of Gastroenterology, 2004, 39 : 1158 - 1164
[2] Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study
Fukuda, Y
Matsui, T
Suzuki, Y
Kanke, K
Matsumoto, T
Takazoe, M
Matsumoto, T
Motoya, S
Honma, T
Sawada, K
Yao, T
Shimoyama, T
Hibi, T
JOURNAL OF GASTROENTEROLOGY, 2004, 39 (12) : 1158 - 1164
[3] SAFETY AND EFFECTIVENESS OF GRANULOCYTE AND MONOCYTE ADSORPTIVE APHERESIS IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A MULTICENTER COHORT STUDY
Toita, Nariaki
Tanaka, Hiroki
Arai, Katsuhiro
Shimizu, Hirotaka
Abukawa, Daiki
Kobayashi, Toshihisa
Yoshimura, Naoki
Tanida, Satoshi
Hosoi, Eiji
GASTROENTEROLOGY, 2019, 156 (06) : S667 - S667
[4] Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis
Yamamoto, Takayuki
Umegae, Satoru
Matsumoto, Koichi
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (04) : 520 - 525
[5] Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis
TakayukiYamamoto
SatoruUmegae
KoichiMatsumoto
World Journal of Gastroenterology, 2006, (04) : 520 - 525
[6] Immunoregulatory Effects of Adsorptive Granulocyte and Monocyte Apheresis in Patients with Drug Refractory Crohn's Disease
Nagase, Kazuko
Fukunaga, Ken
Kashiwamura, Shinichiro
Kono, Tomoaki
Kamikozuru, Koji
Yokoyama, Yoko
Hida, Nobuyuki
Ohda, Yoshio
Takeda, Naohisa
Yoshida, Koji
Iimuro, Masaki
Kikuyama, Risa
Kato, Kyoichi
Miwa, Hiroto
Matsumoto, Takayuki
THERAPEUTIC APHERESIS AND DIALYSIS, 2011, 15 (04) : 367 - 373
[7] A retrospective study to investigate the efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with primary sclerosing cholangitis with ulcerative colitis
Ito, Ayumi
Murasugi, Shun
Yonezawa, Maria
Omori, Teppei
Nakamura, Shinichi
Tokushige, Katsutoshi
JOURNAL OF CLINICAL APHERESIS, 2024, 39 (01)
[8] Clinical predictors associated with remission in Crohn's disease after granulocyte-monocyte adsorptive apheresis
Yamashita, Masaki
Ishii, Manabu
Tanaka, Hiroki
Motoya, Satoshi
Imamura, Akimichi
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 161 - 161
[9] SAFETY AND EFFECTIVENESS OF GRANULOCYTE AND MONOCYTE ADSORPTIVE APHERESIS IN 125 ELDERLY PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A MULTICENTER COHORT STUDY
Tanaka, Hiroki
Motoya, Satoshi
Shibuya, Tomoyoshi
Osada, Taro
Ito, Ayumi
Kobayashi, Toshihisa
Kunisaki, Reiko
Hongo, Hitoshi
Tanida, Satoshi
Kokuma, Seiichiro
Hosoi, Eiji
GASTROENTEROLOGY, 2018, 154 (06) : S996 - S997
[10] Pilot study on the safety and efficacy of granulocyte/monocyte adsorption apheresis with adacolumn in patients with inflammatory bowel disease
Sands, BE
Sandborn, WJ
Wolf, DC
Katz, S
Safdi, M
Schwartz, DA
Hanauer, SB
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S263 - S264

← 1 2 3 4 5 →